NovoLog FlexPen and Trastuzumab and Hyaluronidase
Determining the interaction of NovoLog FlexPen and Trastuzumab and Hyaluronidase and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: insulin aspart
Brand name: Fiasp, NovoLog, NovoLog FlexPen, NovoLog PenFill, NovoLOG FlexTouch, Fiasp PenFill, Fiasp FlexTouch
Synonyms: n.a.
Generic Name: hyaluronidase / trastuzumab
Brand name: Herceptin Hylecta
Synonyms: Hyaluronidase and trastuzumab
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- NovoLog FlexPen-Trastuzumab Injection (Intravenous)
- NovoLog FlexPen-Trastuzumab Intravenous
- NovoLog FlexPen-Trastuzumab-anns
- NovoLog FlexPen-Trastuzumab-dkst
- NovoLog FlexPen-Trastuzumab-dkst Intravenous
- NovoLog FlexPen-Trasylol
- Trastuzumab and Hyaluronidase-Novolog Injection
- Trastuzumab and Hyaluronidase-NovoLog Mix 70/30
- Trastuzumab and Hyaluronidase-NovoLog Mix 70/30 (Insulin Aspart Protamine and Insulin Aspart (Cartridges and Prefilled Pens))
- Trastuzumab and Hyaluronidase-NovoLog Mix 70/30 (Insulin Aspart Protamine and Insulin Aspart (Vials))
- Trastuzumab and Hyaluronidase-NovoLog Mix 70/30 FlexPen
- Trastuzumab and Hyaluronidase-NovoLog PenFill